Topical preparation series
Share:
Product Specification:15g:1%(15g:0.15g)
Indications:
It is suitable for patients with mild to moderate atopic dermatitis of 3 months and older who are not immunocompromised:
For short-term treatment of signs and symptoms of the disease.
For long-term intermittent treatment to prevent disease exacerbation.
For children under 24 months of age with mild to moderate atopic dermatitis, this product should be used in patients who cannot or should not be treated with topical glucocorticoids.
Product Features
Pimecrolimus Cream is a non-hormonal anti-inflammatory drug
Low transdermal absorption, high safety, suitable for children and long-term eczema prevention and treatment.